热门资讯> 正文
Akebia Therapeutics Q3 Sales $58.766M Beat $58.235M Estimate
2025-11-10 20:04
Akebia Therapeutics (NASDAQ: AKBA) reported quarterly sales of $58.766 million which beat the analyst consensus estimate of $58.235 million by 0.91 percent. This is a 57.01 percent increase over sales of $37.428 million the same period last year.
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
